David M Reid

Author PubWeight™ 157.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010 12.27
2 Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010 9.90
3 Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010 8.89
4 Rheumatoid arthritis association at 6q23. Nat Genet 2007 6.71
5 Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med 2010 5.60
6 Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012 5.48
7 Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009 3.52
8 Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat Genet 2008 3.18
9 Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 2004 2.83
10 Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum 2006 2.82
11 The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med 2006 2.74
12 Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 2008 2.52
13 Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet 2011 2.34
14 Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 2004 2.20
15 The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. J Am Dent Assoc 2010 2.19
16 Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet 2008 2.08
17 Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. J Bone Miner Res 2004 2.01
18 Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum 2009 1.95
19 Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease. Arthritis Res Ther 2010 1.85
20 Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women. J Natl Cancer Inst 2010 1.79
21 Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med 2006 1.68
22 Lower estimates of net endogenous non-carbonic acid production are positively associated with indexes of bone health in premenopausal and perimenopausal women. Am J Clin Nutr 2004 1.67
23 A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 2014 1.56
24 Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes. Hum Mol Genet 2009 1.55
25 Randomized controlled trial of hip protectors among women living in the community. Osteoporos Int 2004 1.53
26 Radiographic features of lumbar disc degeneration and self-reported back pain. J Rheumatol 2004 1.46
27 Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. Hum Mol Genet 2005 1.42
28 Bisphosphonate-associated osteonecrosis of the jaw. Menopause Int 2007 1.41
29 Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012 1.39
30 Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum Mol Genet 2009 1.37
31 Low dietary potassium intakes and high dietary estimates of net endogenous acid production are associated with low bone mineral density in premenopausal women and increased markers of bone resorption in postmenopausal women. Am J Clin Nutr 2005 1.30
32 Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial. Am J Clin Nutr 2008 1.29
33 Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif Tissue Int 2008 1.26
34 Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone 2008 1.26
35 Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 2010 1.21
36 Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol 2008 1.18
37 Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: results from the 1958 British Birth Cohort Study. Pain 2010 1.17
38 Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 2004 1.14
39 Uncoupling light quality from light irradiance effects in Helianthus annuus shoots: putative roles for plant hormones in leaf and internode growth. J Exp Bot 2007 1.14
40 Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone 2007 1.07
41 Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study. Ann Rheum Dis 2009 1.07
42 PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis 2009 1.06
43 Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study. Bone 2013 1.05
44 Influence of weight, body mass index and lifestyle factors on radiographic features of lumbar disc degeneration. Ann Rheum Dis 2007 1.03
45 Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women. Osteoporos Int 2004 1.03
46 Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology (Oxford) 2010 1.03
47 Predicting OA progression to total hip replacement: can we do better than risk factors alone using active shape modelling as an imaging biomarker? Rheumatology (Oxford) 2011 1.02
48 Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women. Eur J Hum Genet 2012 1.02
49 Long-term fracture prediction by DXA and QUS: a 10-year prospective study. J Bone Miner Res 2005 1.01
50 Lumbar disc degeneration: association between osteophytes, end-plate sclerosis and disc space narrowing. Ann Rheum Dis 2006 0.99
51 Involvement of gibberellins in the stem elongation of sun and shade ecotypes of Stellaria longipes that is induced by low light irradiance. Plant Cell Environ 2006 0.99
52 Dietary silicon interacts with oestrogen to influence bone health: evidence from the Aberdeen Prospective Osteoporosis Screening Study. Bone 2011 0.97
53 Role of bisphosphonates in the management of postmenopausal osteoporosis: an update on recent safety anxieties. Menopause Int 2011 0.97
54 Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nat Clin Pract Rheumatol 2008 0.97
55 Large-scale population-based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women. J Bone Miner Res 2005 0.96
56 Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom 2008 0.94
57 Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. Hum Mol Genet 2002 0.93
58 Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study. Bone 2008 0.91
59 Longitudinal changes in dietary intake in Scottish women around the menopause: changes in dietary pattern result in minor changes in nutrient intake. Public Health Nutr 2005 0.90
60 Interspecies synteny mapping identifies a quantitative trait locus for bone mineral density on human chromosome Xp22. Hum Mol Genet 2005 0.89
61 Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women. J Bone Miner Res 2013 0.88
62 PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton. Calcif Tissue Int 2007 0.87
63 Identification of hip fracture patients from radiographs using Fourier analysis of the trabecular structure: a cross-sectional study. BMC Med Imaging 2004 0.87
64 Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. Bone 2011 0.87
65 The characterisation and determinants of quality of life in ANCA associated vasculitis. Ann Rheum Dis 2013 0.87
66 Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture. Osteoporos Int 2004 0.87
67 RUNX2 alleles associated with BMD in Scottish women; interaction of RUNX2 alleles with menopausal status and body mass index. Bone 2004 0.86
68 Polymorphisms of the CLCN7 gene are associated with BMD in women. J Bone Miner Res 2005 0.85
69 Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population. Ann Rheum Dis 2009 0.84
70 Alterations of the glutathione redox state improve apical meristem structure and somatic embryo quality in white spruce (Picea glauca). J Exp Bot 2005 0.84
71 A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus. J Med Genet 2013 0.84
72 Methane emissions from six crop species exposed to three components of global climate change: temperature, ultraviolet-B radiation and water stress. Physiol Plant 2009 0.84
73 Aspiration of alendronic acid leading to localized bronchiectasis. Eur J Clin Pharmacol 2011 0.84
74 Haplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in women. J Clin Endocrinol Metab 2006 0.83
75 Quantitative ultrasound in osteoporosis. Semin Musculoskelet Radiol 2002 0.83
76 Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am J Clin Nutr 2008 0.83
77 Associations between dietary flavonoid intakes and bone health in a Scottish population. J Bone Miner Res 2011 0.83
78 Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis. Bone 2012 0.83
79 Tree-structured subgroup analysis of receiver operating characteristic curves for diagnostic tests. Acad Radiol 2012 0.83
80 The functional ACTN3 577X variant increases the risk of falling in older females: results from two large independent cohort studies. J Gerontol A Biol Sci Med Sci 2010 0.82
81 A rare haplotype in the upstream regulatory region of COL1A1 is associated with reduced bone quality and hip fracture. J Bone Miner Res 2009 0.81
82 Large-scale population-based study shows no association between common polymorphisms of the TGFB1 gene and BMD in women. J Bone Miner Res 2007 0.81
83 Growth and ethylene evolution by shade and sun ecotypes of Stellaria longipes in response to varied light quality and irradiance. Plant Cell Environ 2006 0.81
84 Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci. Rheumatology (Oxford) 2009 0.81
85 The interaction of light quality and irradiance with gibberellins, cytokinins and auxin in regulating growth of Helianthus annuus hypocotyls. Plant Cell Environ 2007 0.80
86 Skin color change in Caucasian postmenopausal women predicts summer-winter change in 25-hydroxyvitamin D: findings from the ANSAViD cohort study. J Clin Endocrinol Metab 2011 0.80
87 Bone shape, structure, and density as determinants of osteoporotic hip fracture: a pilot study investigating the combination of risk factors. Invest Radiol 2005 0.80
88 Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial. Circulation 2010 0.80
89 Changes in vitamin biomarkers during a 2-year intervention trial involving increased fruit and vegetable consumption by free-living volunteers. Br J Nutr 2009 0.80
90 Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from Scotland. J Bone Miner Res 2004 0.79
91 Explaining fatigue in ANCA-associated vasculitis. Rheumatology (Oxford) 2013 0.78
92 Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 2012 0.78
93 Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids. Rheumatology (Oxford) 2013 0.78
94 Seasonal variation in 25(OH)D at Aberdeen (57°N) and bone health indicators--could holidays in the sun and cod liver oil supplements alleviate deficiency? PLoS One 2013 0.78
95 Light irradiance differentially regulates endogenous levels of cytokinins and auxin in alpine and prairie genotypes of Stellaria longipes. Physiol Plant 2008 0.78
96 THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women. Eur J Endocrinol 2014 0.76
97 Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women. Bone 2010 0.76
98 Ethylene involvement in silique and seed development of canola, Brassica napus L. Plant Physiol Biochem 2012 0.76
99 No evidence for association of the KLF12 gene with rheumatoid arthritis in a large UK cohort. Ann Rheum Dis 2009 0.76
100 Aerobic methane emissions from stinkweed (Thlaspi arvense) capsules. Plant Signal Behav 2014 0.75
101 Lifestyle factors for promoting bone health in older women. J Adv Nurs 2004 0.75
102 Bisphosphonates: when and for whom? J Br Menopause Soc 2003 0.75
103 Alternative population sampling frames produced important differences in estimates of association: a case-control study of vasculitis. J Clin Epidemiol 2013 0.75
104 Impact of trochanteric heterotopic ossification on measurement of femoral bone density following cemented total hip replacement. J Orthop Res 2008 0.75
105 Managing osteoporosis. Practitioner 2004 0.75
106 Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford) 2014 0.75
107 Fatigue-related brain white matter changes in granulomatosis with polyangiitis. Rheumatology (Oxford) 2013 0.75
108 Non-steroidal anti-inflammatory drugs and atherothrombotic risk in older patients: where do we stand? Age Ageing 2010 0.75